Search hospitals > California > Bakersfield
AIS Cancer Center at San Joaquin Community Hospital
Claim this profileBakersfield, California 93301
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Bladder Cancer
46 reported clinical trials
4 medical researchers
Summary
AIS Cancer Center at San Joaquin Community Hospital is a medical facility located in Bakersfield, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Bladder Cancer and other specialties. AIS Cancer Center at San Joaquin Community Hospital is involved with conducting 46 clinical trials across 229 conditions. There are 4 research doctors associated with this hospital, such as Tianhong Li, Luis Mariscal, Ricardo Salas, and Nicole Gordon.Area of expertise
1Cancer
Global LeaderStage I
Stage II
Stage IV
2Lung Cancer
Global LeaderStage II
Stage I
Stage III
Top PIs
Tianhong LiUniversity of California Davis Comprehensive Cancer Center1 year of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Solid Tumors
11 reported clinical trials
16 drugs studied
Luis MariscalAIS Cancer Center at San Joaquin Community Hospital4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
24 drugs studied
Ricardo SalasAIS Cancer Center at San Joaquin Community Hospital3 years of reported clinical research
Studies Diabetes
Studies Type 2 Diabetes
4 reported clinical trials
20 drugs studied
Nicole GordonAIS Cancer Center at San Joaquin Community Hospital1 year of reported clinical research
Studies Breast Cancer
Studies Cancer
3 reported clinical trials
8 drugs studied
Clinical Trials running at AIS Cancer Center at San Joaquin Community Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Cancer
ALK Gene Rearrangement
Prostate Adenocarcinoma
Cognitive Impairment
Adenocarcinoma
Lung Carcinoma
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at AIS Cancer Center at San Joaquin Community Hospital?
AIS Cancer Center at San Joaquin Community Hospital is a medical facility located in Bakersfield, California. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Bladder Cancer and other specialties. AIS Cancer Center at San Joaquin Community Hospital is involved with conducting 46 clinical trials across 229 conditions. There are 4 research doctors associated with this hospital, such as Tianhong Li, Luis Mariscal, Ricardo Salas, and Nicole Gordon.